1248 Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.17M Buy
1,807
+292
+19% +$298K 0.85% 18
2026
Q1
$1.39M Hold
1,515
0.65% 22
2025
Q4
$1.63M Hold
1,515
0.87% 16
2025
Q3
$1.16M Sell
1,515
-439
-22% -$327K 0.65% 18
2025
Q2
$1.52M Buy
1,954
+24
+1% +$18.6K 0.56% 28
2025
Q1
$1.59M Sell
1,930
-21
-1% -$17.5K 0.68% 23
2024
Q4
$1.51M Buy
+1,951
New +$1.62M 0.65% 27

Other funds holding LLY

1248 Management's LLY Position: Q2 2026 in Review

1248 Management increased its Eli Lilly (LLY) stake by 19% in Q2 2026, buying an estimated $298K and bringing the position to 1,807 shares worth $2.17M. The position accounts for 0.85% of the portfolio, ranked #18.

1248 Management first reported a position in LLY in Q4 2024 and has held it in 7 quarters since. 4,634 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • 1248 Management held 1,807 shares of Eli Lilly worth $2.17M as of Q2 2026.
  • 1248 Management bought 292 Eli Lilly shares in Q2 2026, an estimated $298K.
  • Eli Lilly made up 0.85% of 1248 Management's portfolio in Q2 2026, its #18 holding.
  • 1248 Management first reported a position in Eli Lilly in Q4 2024 and has held it in 7 quarters since.
  • 4,634 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on 1248 Management's 13F filing for Q2 2026, filed 13 Aug 2026.